ClinicalTrials.gg
RecruitingNCT07521319BBTi-COMISAUpdated Oct 15, 2026

Wearable Voice-Guided BBTi for Comorbid Insomnia and Sleep Apnea (COMISA)

An interventional study of Brief Behavioral Therapy for Insomnia (BBTi) and Smart Eye-Mask with Voice-Guided Modules in Comorbid Insomnia and Sleep Apnea, Insomnia and Obstructive Sleep Apnea, sponsored by National Sun Yat-sen University. Recruiting at 1 site in Taiwan. Open to participants aged 20 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-10-15.

Primary conditionSleep Apnea, ObstructiveRegistry: Sleep Apnea SyndromesReclassifiedWhy we changed it
Registry
Sleep Apnea Syndromes — the first condition term the registry derived for this study.
ClinicalTrials.gg
Sleep Apnea, Obstructive
Why
  1. The study's listed conditions name Sleep Apnea, Obstructive, a narrower term within Sleep Apnea Syndromes.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by National Sun Yat-sen University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Aug 2026; still recruiting 3 months later.
Updated Oct 15, 2026Now RecruitingFirst site in Taiwan+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
361
Allocation
Randomized
Ages
20 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 90 studies in Sleep Apnea, Obstructive with a site in Taiwan — 26 open to participants now, 27 under way, 3 of them phase 3. Sleep Apnea, Obstructive · Taiwan.

Planned enrollment
4th of 58
361 · median 71
Started
2026
with 9 others
No phase
51 of 90
16 open now
Primary completion
2030-07
later than 24 of 26 live
Registered
83rd of 90
by date

Among the 90 studies in Sleep Apnea, Obstructive with a site in Taiwan, this one is the 4th largest by planned enrollment of the 58 interventional ones that give a count, is one of 10 that started in 2026, is one of 51 with no phase, reaches primary completion later than 24 of the 26 other live ones, and was the 83rd registered.

Sleep Apnea, Obstructive

2,246 studies on the registry are indexed under Sleep Apnea, Obstructive; 476 are open to participants now.

Browse Sleep Apnea, Obstructive studies →

Open to participants now

26 of the 90 studies in Sleep Apnea, Obstructive with a site in Taiwan are open now. Recruiting first, the newest first:

20 more — sign in →

All 26 open studies →

A study can be open while its sites in Taiwan have not opened yet or have stopped. Only those recruiting at a site in Taiwan →

Who these studies take

Of the 317 Sleep Apnea, Obstructive studies recruiting now, 149 (47%) set no upper age limit and 124 (39%) stop at 75 or younger; 53 take children under 18; 66 take healthy volunteers.

This study: 20 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 90 studies in Sleep Apnea, Obstructive with a site in Taiwan, or all of them as a file.
02

Study summary

This study investigates the efficacy of a wearable voice-guided Brief Behavioral Therapy for Insomnia (BBTi) combined with a smart eye-mask device for individuals with Comorbid Insomnia and Sleep Apnea (COMISA). The four-year study comprises three phases: (1) exploration of cognitive-emotion regulation-arousal system mechanisms in COMISA and pilot BBTi intervention testing, (2) development and usability testing of an integrated smart eye-mask with BBTi voice-guided modules, and (3) a multi-center randomized controlled trial (RCT) evaluating the combined BBTi plus smart eye-mask intervention versus BBTi alone, smart eye-mask alone, and standard sleep hygiene education in 160 COMISA participants. Primary outcomes include insomnia severity (ISI), daytime sleepiness (ESS), and CPAP adherence. The study aims to establish an evidence-based digital health intervention for improving sleep outcomes in COMISA patients.

Read the detailed description

Comorbid Insomnia and Sleep Apnea (COMISA) affects approximately 30-50% of OSA patients and is associated with more severe symptoms, poorer treatment outcomes, and greater functional impairment than either condition alone. Brief Behavioral Therapy for Insomnia (BBTi) has been shown effective for insomnia management in fewer sessions than traditional CBTi. This study combines BBTi with wearable technology - a smart eye-mask integrating voice-guided relaxation, thermal massage, and physiological monitoring via an actigraphy watch - to provide an accessible, home-based intervention.

Phase 1 (Specific Aim 1, 2026-2027): A mixed-methods sequential explanatory design involving (a) a cross-sectional survey (n=181) examining dysfunctional beliefs about sleep (DBAS), cognitive emotion regulation (CERQ), arousal predisposition (APS), pre-sleep arousal (PSAS), insomnia severity (ISI), and daytime sleepiness (ESS) in insomnia-only versus COMISA patients; (b) qualitative interviews (n=10-15) exploring subjective experiences; and (c) a quasi-experimental pilot (n=40) testing 4-week BBTi in COMISA (n=20) versus insomnia-only (n=20) participants.

Phase 2 (Specific Aim 2, 2028): Development of the integrated smart eye-mask system with BBTi voice-guided micro-learning modules (sleep hygiene, stimulus control, sleep restriction, relaxation/breathing training, positive emotion guidance), followed by expert review and usability testing with 10 COMISA participants.

Phase 3 (Specific Aim 3, 2029-2030): A multi-center, parallel-group, double-blind RCT at National Cheng Kung University Hospital and Armed Forces Kaohsiung General Hospital (802). 160 COMISA participants are randomized to four arms: (1) BBTi + smart eye-mask, (2) BBTi alone, (3) smart eye-mask alone, (4) standard sleep hygiene education (control). Assessments at baseline, 4 weeks, and 1- and 3-month follow-ups include DBAS, CERQ, APS, PSAS, ISI, ESS, sleep diary, actigraphy parameters, HRV, and CPAP adherence.

03

Conditions studied

  • Comorbid Insomnia and Sleep Apnea
  • Insomnia
  • Obstructive Sleep Apnea

Keywords

  • BBTi
  • COMISA
  • CPAP
  • Wearable Device
  • Sleep
04

In context

Sleep Apnea, Obstructive Reclassified

2,246 studies on the registry are indexed under Sleep Apnea, Obstructive; 476 are open to participants now.

This study's planned enrollment of 361 is above the median of 52 across 1,476 interventional studies indexed under Sleep Apnea, Obstructive.

Browse Sleep Apnea, Obstructive studies →

Lead sponsor

National Sun Yat-sen University is the lead sponsor of 6 studies on the registry; 5 are open to participants now.

Compared within Sleep Apnea, Obstructive, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Sleep Apnea Syndromes. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
20 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥20 years.
  • Obstructive sleep apnea (OSA) diagnosed by clinical polysomnography (PSG), defined as apnea-hypopnea index (AHI) ≥5 events/hour.
  • Insomnia disorder diagnosed by a physician according to criteria, with Insomnia Severity Index (ISI) score ≥15.
  • Able to understand study procedures and provide written .

Exclusion criteria

Exclusion Criteria:

  • Severe cognitive impairment,
  • Major psychiatric disorder,
  • Severe chronic illness (e.g., severe heart failure or receiving hemodialysis).
  • Other sleep disorders (e.g., restless legs syndrome, narcolepsy, circadian rhythm sleep-wake disorders).
  • Receipt of CBT-I, BBTi, or other behavioral sleep interventions within the past 3 months.
  • Pregnant or breastfeeding.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

06

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
361 participants (estimated)

Study arms

  • Experimental
    BBTi + Smart Eye-Mask

    Participants receive 4-week Brief Behavioral Therapy for Insomnia (BBTi) at clinic plus nightly use of smart eye-mask with voice-guided BBTi modules at home for 15-20 minutes.

    Behavioral: Brief Behavioral Therapy for Insomnia (BBTi) · Device: Smart Eye-Mask with Voice-Guided Modules

  • Active comparator
    BBTi Alone

    Participants receive 4-week Brief Behavioral Therapy for Insomnia (BBTi) including sleep hygiene education, sleep restriction, stimulus control, and relaxation/breathing training.

    Behavioral: Brief Behavioral Therapy for Insomnia (BBTi)

  • Active comparator
    Smart Eye-Mask Alone

    Participants use smart eye-mask with voice-guided modules nightly for 4 weeks without structured BBTi intervention.

    Device: Smart Eye-Mask with Voice-Guided Modules

  • No intervention
    Standard Sleep Hygiene Education

    Participants receive standard sleep hygiene education materials only.

Interventions

  • BehavioralBrief Behavioral Therapy for Insomnia (BBTi)

    A 4-week structured behavioral sleep intervention including sleep hygiene education, sleep restriction, stimulus control, and relaxation/breathing training.

  • DeviceSmart Eye-Mask with Voice-Guided Modules

    A wearable smart eye-mask device integrating thermal regulation (41-42C), air-pressure rhythmic eye massage (50-70 mmHg), and BBTi voice-guided micro-learning modules covering sleep hygiene, stimulus control, relaxation/breathing, body scan, and positive emotion guidance.

07

What researchers measure

Primary outcomes

  1. Change in Insomnia Severity Index (ISI)_T0

    Change in insomnia severity measured by the ISI, a 7-item self-report questionnaire scored 0-28, with higher scores indicating more severe insomnia.

    Time frame: Baseline

  2. Change in Insomnia Severity Index (ISI)_T1

    Change in insomnia severity measured by the ISI, a 7-item self-report questionnaire scored 0-28, with higher scores indicating more severe insomnia.

    Time frame: 4 weeks

  3. Change in Insomnia Severity Index (ISI)_T2

    Change in insomnia severity measured by the ISI, a 7-item self-report questionnaire scored 0-28, with higher scores indicating more severe insomnia.

    Time frame: 1 months follow-up

  4. Change in Insomnia Severity Index (ISI)_T3

    Change in insomnia severity measured by the ISI, a 7-item self-report questionnaire scored 0-28, with higher scores indicating more severe insomnia.

    Time frame: 3 months follow-up

  5. Change in Arousal Predisposition Scale (APS)_T0

    Change in hyperarousal measured by the APS, an 12-item self-report questionnaire scored 12-60, with higher scores indicating greater daytime sleepiness.

    Time frame: Baseline

  6. Change in Arousal Predisposition Scale (APS)_T1

    Change in hyperarousal measured by the APS, an 12-item self-report questionnaire scored 12-60, with higher scores indicating greater daytime sleepiness.

    Time frame: 4 weeks

  7. Change in Arousal Predisposition Scale (APS)_T2

    Change in hyperarousal measured by the APS, an 12-item self-report questionnaire scored 12-60, with higher scores indicating greater daytime sleepiness.

    Time frame: 1 month follow-up

  8. Change in Arousal Predisposition Scale (APS)_T3

    Change in hyperarousal measured by the APS, an 12-item self-report questionnaire scored 12-60, with higher scores indicating greater daytime sleepiness.

    Time frame: 3 month follow-up

  9. Change in Pre-Sleep Arousal Scale (PSAS)_T0

    Change in pre-sleep arousal measured by the PSAS, an 16-item self-report questionnaire scored 16-80, with higher scores indicating higher pre-sleep arousal.

    Time frame: Baseline

  10. Change in Pre-Sleep Arousal Scale (PSAS)_T1

    Change in pre-sleep arousal measured by the PSAS, an 16-item self-report questionnaire scored 16-80, with higher scores indicating higher pre-sleep arousal.

    Time frame: 4 weeks

  11. Change in Pre-Sleep Arousal Scale (PSAS)_T2

    Change in pre-sleep arousal measured by the PSAS, an 16-item self-report questionnaire scored 16-80, with higher scores indicating higher pre-sleep arousal.

    Time frame: 1 month follow-up

  12. Change in Pre-Sleep Arousal Scale (PSAS)_T3

    Change in pre-sleep arousal measured by the PSAS, an 16-item self-report questionnaire scored 16-80, with higher scores indicating higher pre-sleep arousal.

    Time frame: 3 month follow-up

  13. Change in Cognitive Emotion Regulation Questionnaire (CERQ)_T0

    Change in cognitive emotion regulation measured by the CERQ, a 36-item self-report measure assessing nine cognitive emotion regulation strategies (four items per strategy). Items are rated on a 5-point Likert scale (1-5). Subscale scores are calculated by summing item scores; higher subscale scores indicate more frequent use of the corresponding strategy.

    Time frame: Baseline

  14. Change in Cognitive Emotion Regulation Questionnaire (CERQ)_T1

    Change in cognitive emotion regulation measured by the CERQ, a 36-item self-report measure assessing nine cognitive emotion regulation strategies (four items per strategy). Items are rated on a 5-point Likert scale (1-5). Subscale scores are calculated by summing item scores; higher subscale scores indicate more frequent use of the corresponding strategy.

    Time frame: 4 weeks

  15. Change in Cognitive Emotion Regulation Questionnaire (CERQ)_T2

    Change in cognitive emotion regulation measured by the CERQ, a 36-item self-report measure assessing nine cognitive emotion regulation strategies (four items per strategy). Items are rated on a 5-point Likert scale (1-5). Subscale scores are calculated by summing item scores; higher subscale scores indicate more frequent use of the corresponding strategy.

    Time frame: 1 month follow-up

  16. Change in Cognitive Emotion Regulation Questionnaire (CERQ)_T3

    Change in cognitive emotion regulation measured by the CERQ, a 36-item self-report measure assessing nine cognitive emotion regulation strategies (four items per strategy). Items are rated on a 5-point Likert scale (1-5). Subscale scores are calculated by summing item scores; higher subscale scores indicate more frequent use of the corresponding strategy.

    Time frame: 3 month follow-up

  17. Change in subjective sleep diary_T0

    Change in subjective sleep quality measured by the self-report sleep diary. Participants will complete a daily sleep diary to assess subjective sleep. Recorded items include bedtime, sleep onset time, number of awakenings, final awakening time, time out of bed, and self-rated sleep quality (1-10, with higher scores indicating better sleep quality).

    Time frame: Baseline

  18. Change in subjective sleep diary_T1

    Change in subjective sleep quality measured by the self-report sleep diary. Participants will complete a daily sleep diary to assess subjective sleep. Recorded items include bedtime, sleep onset time, number of awakenings, final awakening time, time out of bed, and self-rated sleep quality (1-10, with higher scores indicating better sleep quality).

    Time frame: 4 weeks

  19. Change in subjective sleep diary_T2

    Change in subjective sleep quality measured by the self-report sleep diary. Participants will complete a daily sleep diary to assess subjective sleep. Recorded items include bedtime, sleep onset time, number of awakenings, final awakening time, time out of bed, and self-rated sleep quality (1-10, with higher scores indicating better sleep quality).

    Time frame: 1 month follow-up

  20. Change in subjective sleep parameter_T3

    Change in subjective sleep parameter measured by the self-report sleep diary. Participants will complete a daily sleep diary to assess subjective sleep. Recorded items include bedtime, sleep onset time, number of awakenings, final awakening time, time out of bed, and self-rated sleep quality (1-10, with higher scores indicating better sleep quality).

    Time frame: 3 month follow-up

  21. Change in Epworth Sleepiness Scale (ESS)_T0

    Change in daytime sleepiness measured by the ESS, an 8-item self-report questionnaire scored 0-24, with higher scores indicating greater daytime sleepiness.

    Time frame: Baseline

  22. Change in Epworth Sleepiness Scale (ESS)_T1

    Change in daytime sleepiness measured by the ESS, an 8-item self-report questionnaire scored 0-24, with higher scores indicating greater daytime sleepiness.

    Time frame: 4 weeks

  23. Change in Epworth Sleepiness Scale (ESS)_T2

    Change in daytime sleepiness measured by the ESS, an 8-item self-report questionnaire scored 0-24, with higher scores indicating greater daytime sleepiness.

    Time frame: 1 month follow-up

  24. Change in Epworth Sleepiness Scale (ESS)_T3

    Change in daytime sleepiness measured by the ESS, an 8-item self-report questionnaire scored 0-24, with higher scores indicating greater daytime sleepiness.

    Time frame: 3 months follow-up

  25. Change in objective sleep parameter(total sleep time)_T0

    Change in objective sleep parameters measured by actigraphy. Total sleep time (minutes) is automatically calculated and exported by the actigraphy device using its built-in algorithms.

    Time frame: Baseline

  26. Change in objective sleep parameter(total sleep time)_T1

    Change in objective sleep parameters measured by actigraphy. Total sleep time (minutes) is automatically calculated and exported by the actigraphy device using its built-in algorithms.

    Time frame: 4 weeks

  27. Change in objective sleep parameter(total sleep time)_T2

    Change in objective sleep parameters measured by actigraphy. Total sleep time (minutes) is automatically calculated and exported by the actigraphy device using its built-in algorithms.

    Time frame: 1 months follow-up

  28. Change in objective sleep parameter(total sleep time)_T3

    Change in objective sleep parameters measured by actigraphy. Total sleep time (minutes) is automatically calculated and exported by the actigraphy device using its built-in algorithms.

    Time frame: 3 months follow-up

  29. Change in objective sleep parameter(sleep latency)_T0

    Change in objective sleep parameters measured by actigraphy. Sleep latency (minutes) is automatically calculated and exported by the actigraphy device using its built-in algorithms.

    Time frame: Baseline

  30. Change in objective sleep parameter(sleep latency)_T1

    Change in objective sleep parameters measured by actigraphy. Sleep latency (minutes) is automatically calculated and exported by the actigraphy device using its built-in algorithms.

    Time frame: 4 weeks

  31. Change in objective sleep parameter(sleep latency)_T2

    Change in objective sleep parameters measured by actigraphy. Sleep latency (minutes) is automatically calculated and exported by the actigraphy device using its built-in algorithms.

    Time frame: 1 month follow-up

  32. Change in objective sleep parameter(sleep latency)_T3

    Change in objective sleep parameters measured by actigraphy. Sleep latency (minutes) is automatically calculated and exported by the actigraphy device using its built-in algorithms.

    Time frame: 3 month follow-up

  33. Change in objective sleep parameter(number of awakenings)_T0

    Change in objective sleep parameters measured by actigraphy. Number of awakenings (counts) is automatically calculated and exported by the actigraphy device using its built-in algorithms.

    Time frame: Baseline

  34. Change in objective sleep parameter(number of awakenings)_T1

    Change in objective sleep parameters measured by actigraphy. Number of awakenings (counts) is automatically calculated and exported by the actigraphy device using its built-in algorithms.

    Time frame: 4 weeks

  35. Change in objective sleep parameter(number of awakenings)_T2

    Change in objective sleep parameters measured by actigraphy. Number of awakenings (counts) is automatically calculated and exported by the actigraphy device using its built-in algorithms.

    Time frame: 1 month follow-up

  36. Change in objective sleep parameter(number of awakenings)_T3

    Change in objective sleep parameters measured by actigraphy. Number of awakenings (counts) is automatically calculated and exported by the actigraphy device using its built-in algorithms.

    Time frame: 3 month follow-up

  37. Change in objective sleep parameter(sleep efficiency)_T0

    Change in objective sleep parameters measured by actigraphy. Sleep efficiency (%) is automatically calculated and exported by the actigraphy device using its built-in algorithms.

    Time frame: Baseline

  38. Change in objective sleep parameter(sleep efficiency)_T1

    Change in objective sleep parameters measured by actigraphy. Sleep efficiency (%) is automatically calculated and exported by the actigraphy device using its built-in algorithms.

    Time frame: 4 weeks

  39. Change in objective sleep parameter(sleep efficiency)_T2

    Change in objective sleep parameters measured by actigraphy. Sleep efficiency (%) is automatically calculated and exported by the actigraphy device using its built-in algorithms.

    Time frame: 1 month follow-up

  40. Change in objective sleep parameter(sleep efficiency)_T3

    Change in objective sleep parameters measured by actigraphy. Sleep efficiency (%) is automatically calculated and exported by the actigraphy device using its built-in algorithms.

    Time frame: 3 month follow-up

  41. CPAP Adherence_T0

    CPAP usage compliance measured as the percentage of nights with CPAP use of 4 or more hours divided by total nights multiplied by 100%.

    Time frame: Baseline

  42. CPAP Adherence_T1

    CPAP usage compliance measured as the percentage of nights with CPAP use of 4 or more hours divided by total nights multiplied by 100%.

    Time frame: 4 weeks

  43. CPAP Adherence_T2

    CPAP usage compliance measured as the percentage of nights with CPAP use of 4 or more hours divided by total nights multiplied by 100%.

    Time frame: 1 month follow-up

  44. CPAP Adherence_T3

    CPAP usage compliance measured as the percentage of nights with CPAP use of 4 or more hours divided by total nights multiplied by 100%.

    Time frame: 3 month follow-up

08

Study locations

1 of 1 sites recruiting
09

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2026 (actual). Primary completion is estimated for Jul 2030, 47 months after the start.

Of 511 non-industry interventional studies with no phase under Sleep Apnea, Obstructive, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 53. This study's planned 47 months is above that.

Counting every sponsor, half of 629 studies reached it within 27 months; a quarter within 12 and three quarters within 50.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 23, 2026
First posted
Apr 9, 2026
StartActual
Aug 1, 2026
Primary completionEst.
Jul 31, 2030
CompletionEst.
Dec 31, 2030
Last update
Oct 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Oct 15, 2026
Sites
1 site added — first site in Taiwan
Show site
  • National Cheng Kung University Hospital · Tainan, Taiwan
Oct 15, 2026
Show all 1 update
  1. Oct 15, 2026
    Not yet recruiting→Recruiting
    1 site added — first site in Taiwan
    Show site
    • National Cheng Kung University Hospital · Tainan, Taiwan
    + 2 other changes: verification date and date precision

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT07521319
Lead sponsor
National Sun Yat-sen University
Responsible party
Yen-Chin Chen (Associate Professor, National Sun Yat-sen University) — Principal investigator
First posted
Apr 9, 2026
Start date
Aug 1, 2026
Primary completion
Jul 31, 2030 (estimated)
Completion
Dec 31, 2030 (estimated)
Last update
Oct 15, 2026

Study contacts

Yen-Chin Chen
Contact
yenchin2427@gmail.com
0963412677

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion